Cite
HARVARD Citation
Bonadio, R. et al. (2022). Management of patients with early-stage triple-negative breast cancer following pembrolizumab-based neoadjuvant therapy: What are the evidences?. Cancer treatment reviews. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Bonadio, R. et al. (2022). Management of patients with early-stage triple-negative breast cancer following pembrolizumab-based neoadjuvant therapy: What are the evidences?. Cancer treatment reviews. p. . [Online].